Supported by

CTO (Chronic total occlusion)

Find all the latest content on chronic total occlusion (CTO) published on this website.

Recently we have seen an increase in successful percutaneous coronary interventions (PCI) of CTO in part due to improvements in hardware (guidewires and balloons), the introduction of dedicated devices (microcatheters, channel dilators, dissection-reentry devices) and the elaboration of CTO-specific techniques. To fully grasp CTO today, here you will find here everything that you need to know including the latest devices and techniques as well as advances in imaging, the use of adjunctive pharmacotherapy, vascular access or understanding bleeding risks…

Filtered By
CTO

187 results

The uncrossable lesion

16 May 2024 – From EuroPCR 2024

This session delves into the challenges of dealing with uncrossable and heavily calcified coronary lesions. It features a variety of cases showcasing the use of specialized techniques and tools, such as the excimer laser, to overcome these obstacles. The session emphasizes the importance of troubleshooting, utilizing...

The uncrossable lesion

Stent loss and coronary perforation: how to deal with

16 May 2024 – From EuroPCR 2024

This session explores the management of challenging complications during percutaneous coronary interventions, such as stent loss and coronary perforation. The presenters share case studies that demonstrate various techniques and strategies used to address these complications, including the use of CTO wires for distal wire perforation, managing...

Stent loss and coronary perforation: how to deal with

Challenging scenarios in NSTEMI

16 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions that explore complex and challenging scenarios encountered in the management of NSTEMI patients. Participants will delve into discussions on topics such as coronary artery aneurysm, restenosis of coronary ostial stents, right-sided chest pain, subsequent occlusions of the left anterior...

Challenging scenarios in NSTEMI

The value of IVUS during CTO PCI

16 May 2024 – From EuroPCR 2024

This session explores the role of IVUS imaging in the management of chronic total occlusions (CTOs) during PCI procedures. Participants will learn how IVUS can help in navigating the true lumen, utilizing retrograde plaque/flap lift-and-shift techniques, managing false lumen entry, and addressing other challenging scenarios in...

The value of IVUS during CTO PCI

Upgrade to retrograde: when and how?

16 May 2024 – From EuroPCR 2024

This session delves into the decision-making for transitioning to a retrograde approach in CTO PCI, covering effective techniques and safety considerations for successful outcomes, through cases involving antegradely induced hematomas and ambiguous CTO caps, alongside severe distal atherosclerosis.

Upgrade to retrograde: when and how?

Antegrade CTO - LIVE case

16 May 2024 – From EuroPCR 2024

This session features a LIVE educational case from Netcare Sunninghill Hospital in Johannesburg, South Africa, focusing on the management of chronic total occlusions (CTOs) using an antegrade approach. Participants will learn how to identify CTO anatomy through dual injection, as well as how to perform IVUS-guided...

Antegrade CTO - LIVE case

Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire

16 May 2024 – From EuroPCR 2024

Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...

Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guide

NSTEMI in patients in post CABG: a challenging combination

15 May 2024 – From EuroPCR 2024

This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...

NSTEMI in patients in post CABG: a challenging combination

Stentless PCI

15 May 2024 – From EuroPCR 2024

This session explores various stentless percutaneous coronary intervention (PCI) strategies, including drug-coated balloon (DCB)-only PCI for chronic total occlusions and de-novo coronary lesions, as well as the use of magnesium resorbable scaffolds. Attendees will learn about the rationale, techniques, and outcomes of these "leave nothing behind"...

Stentless PCI

The big challenge: CTO post-CABG

15 May 2024 – From EuroPCR 2024

The big challenge: CTO post-CABG